Is Regional Anesthesia of the Hip Preferable Over Traditional Analgesia in the Acute Stage of the Management of Patients With a Fracture of the Hip
This study is currently recruiting participants.
Verified May 2012 by Landstinget i Värmland
Sponsor:
Landstinget i Värmland
Information provided by (Responsible Party):
Panagiotis Tsagkozis, Landstinget i Värmland
ClinicalTrials.gov Identifier:
NCT01593319
First received: April 30, 2012
Last updated: May 7, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The main hypothesis of the study is that anaesthesia of the hip using infiltration with a local anesthetic solution is preferable over traditional analgesia with oral opioid medications in the acute stage of the management of patients with a fracture of the hip.
To study the hypothesis the investigators designed a prospective randomised study where patients are assigned in two groups, the first receiving local hip anesthesia and the other placebo treatment. Both groups are eligible to use of standard oral pain treatment.
Effect of analgesia as well as medical complications will be recorded.
| Condition | Intervention | Phase |
|---|---|---|
|
Hip Fractures |
Drug: Ropivacaine Drug: Natrium chloride |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) |
Resource links provided by NLM:
Further study details as provided by Landstinget i Värmland:
Primary Outcome Measures:
- Pain [ Time Frame: 3 hours ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- medical complications (Number of participants that develop pressure ulcers, number of participants that develop pneumonia) [ Time Frame: under hospitalization (expected average of 10 days) ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 132 |
| Study Start Date: | January 2012 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Active Comparator: ropivacaine |
Drug: Ropivacaine
Local injection (fascia iliaca block) using 150 mg ropivacaine
Other Name: Narop
|
| Placebo Comparator: Natrium chloride |
Drug: Natrium chloride
Placebo injection of Natrium chloride solution
|
Eligibility| Ages Eligible for Study: | 65 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- fracture of the hip
Exclusion Criteria:
- multiple fractures,
- delay (more than 12 hours) from the time of injury until admission to the hospital,
- local infections, hypersensitivity to local analgetics,
- cognitive impairment
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01593319
Contacts
| Contact: Catharina Nelson, MD | 004654615000 | catharina_nelson@telia.com |
| Contact: Panagiotis Tsagkozis, MD, PhD | 004654615000 | tsagozis@gmail.com |
Locations
| Sweden | |
| Ortopedkliniken, Centralsjukhuset i Karlstad | Recruiting |
| Karlstad, Värmland, Sweden, S-65185 | |
| Contact: Catharina Nelson, MD 0046 54 615000 catharina_nelson@telia.com | |
| Principal Investigator: Panagiotis Tsagkozis, MD, PhD | |
| Sub-Investigator: Catharina Nelson, MD | |
| Sub-Investigator: Rolf Norlin, Professor | |
Sponsors and Collaborators
Landstinget i Värmland
Investigators
| Study Chair: | Anders Hallberg, Forskningsschef | Centrum för klinisk forskning. Centralsjukhuset, 651 85 Karlstad, Sweden |
More Information
Publications:
| Responsible Party: | Panagiotis Tsagkozis, MD, PhD, Landstinget i Värmland |
| ClinicalTrials.gov Identifier: | NCT01593319 History of Changes |
| Other Study ID Numbers: | NAROP11, 2011-003326-27 |
| Study First Received: | April 30, 2012 |
| Last Updated: | May 7, 2012 |
| Health Authority: | Sweden: Regional Ethical Review Board Sweden: Medical Products Agency |
Additional relevant MeSH terms:
|
Fractures, Bone Hip Fractures Wounds and Injuries Femoral Fractures Hip Injuries Leg Injuries Ropivacaine Anesthetics, Local |
Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Sensory System Agents Peripheral Nervous System Agents Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on May 16, 2013